Long-term use of interferon-β in multiple sclerosis increases Vδ1(−)Vδ2(−)Vγ9(−) γδ T cells that are associated with a better outcome

BACKGROUND: We previously reported that Vδ2(+)Vγ9(+) γδ T cells were significantly decreased in multiple sclerosis (MS) patients without disease-modifying therapies (untreated MS) and were negatively correlated with Expanded Disability Status Scale (EDSS) scores, suggesting protective roles of Vδ2(+...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neuroinflammation
Autors principals: Maimaitijiang, Guzailiayi, Watanabe, Mitsuru, Shinoda, Koji, Isobe, Noriko, Nakamura, Yuri, Masaki, Katsuhisa, Matsushita, Takuya, Yoshikai, Yasunobu, Kira, Jun-ichi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743159/
https://ncbi.nlm.nih.gov/pubmed/31519178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-019-1574-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars